This seems so crazy that I want to believe it can't be true, that I'm reading, but this is from the , and is very good reporting.
Questcor Finds Profit for Acthar Drug, at $28,000 a Vial
After pricing its once-obscure drug, Acthar, in the stratosphere, Questcor gained many fans on Wall Street. But the company has also drawn some doubters.
Google+: View post on Google+